Sumito Sato Selected Research

Sumito Sato Research Topics

Disease

17	Neoplasms (Cancer) 05/2022 - 09/2002
11	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 06/2010
6	Rectal Neoplasms (Rectal Cancer) 03/2022 - 04/2015
6	Neoplasm Metastasis (Metastasis) 09/2021 - 01/2003
3	Colonic Neoplasms (Colon Cancer) 10/2021 - 12/2020
3	Breast Neoplasms (Breast Cancer) 12/2012 - 01/2003
3	Ovarian Neoplasms (Ovarian Cancer) 01/2008 - 09/2002
2	Glioma (Gliomas) 11/2023 - 05/2007
2	Glioblastoma (Glioblastoma Multiforme) 04/2021 - 04/2018
2	Parkinson Disease (Parkinson's Disease) 01/2013 - 01/2005
2	Brain Neoplasms (Brain Tumor) 05/2007 - 04/2006
1	Hemorrhoids 01/2023
1	Sclerosis 01/2023
1	Disease Progression 05/2022
1	Cysts 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2021
1	Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy) 06/2021
1	Signet Ring Cell Carcinoma 01/2021
1	Margins of Excision 12/2020
1	Acoustic Neuroma (Acoustic Neurinoma) 05/2015
1	Sigmoid Neoplasms 03/2015
1	Poliomyelitis (Polio) 12/2014
1	Paraparesis 12/2014
1	Splenomegaly 06/2013
1	Lymphoma (Lymphomas) 02/2010
1	Hemifacial Spasm 02/2009
1	Tremor (Tremors) 01/2005
1	Essential Tremor (Essential Tremors) 01/2005

Drug/Important Bio-Agent (IBA)

5	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 12/2012 - 09/2002
4	Bevacizumab (Avastin)FDA Link 02/2022 - 06/2010
3	Messenger RNA (mRNA)IBA 09/2021 - 06/2011
3	Serine Proteases (Serine Protease)IBA 06/2011 - 01/2003
2	AlbuminsIBA 10/2021 - 10/2021
2	Carmustine (FIVB)FDA Link 04/2021 - 04/2018
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2016 - 06/2013
2	XELOXIBA 07/2016 - 06/2013
2	matrigelIBA 06/2011 - 07/2003
2	Urokinase Plasminogen Activator ReceptorsIBA 01/2008 - 01/2003
2	Peptides (Polypeptides)IBA 01/2008 - 09/2002
2	AcidsIBA 05/2007 - 04/2006
1	Therapeutic UsesIBA 01/2023
1	Tannic Acid FDA Link 01/2023
1	aluminum sulfate (alum)IBA 01/2023
1	GadoliniumIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	C-Reactive ProteinIBA 10/2021
1	Chemokine ReceptorsIBA 09/2021
1	CXC ChemokinesIBA 09/2021
1	CC ChemokinesIBA 09/2021
1	Mitochondrial DNA (mtDNA)IBA 06/2021
1	Temozolomide (Temodar)FDA LinkGeneric 04/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Anaplastic Lymphoma KinaseIBA 01/2021
1	Biocompatible Materials (Biomaterials)IBA 04/2018
1	PolymersIBA 04/2018
1	thiamine triphosphorate (TTP)IBA 07/2016
1	Capecitabine (Xeloda)FDA Link 07/2016
1	Capsules (Microcapsules)IBA 01/2016
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 06/2013
1	Extracellular Matrix ProteinsIBA 06/2011
1	Methotrexate (Mexate)FDA LinkGeneric 02/2010
1	PolygelineIBA 01/2008
1	LigandsIBA 01/2008
1	CobaltIBA 01/2005
1	Cysteine Proteases (Cysteine Protease)IBA 07/2003
1	Matrix Metalloproteinases (MMPs)IBA 07/2003
1	Plasminogen Activator Inhibitor 1IBA 01/2003
1	Peptide Hydrolases (Proteases)FDA Link 01/2003
1	Plasminogen Activator Inhibitor 2IBA 01/2003
1	PlasminogenIBA 01/2003
1	Cyclic PeptidesIBA 09/2002

Therapy/Procedure

6	Therapeutics 05/2022 - 01/2008
6	Lymph Node Excision (Lymph Node Dissection) 03/2022 - 12/2014
5	Drug Therapy (Chemotherapy) 05/2022 - 02/2010
4	Colectomy 05/2022 - 03/2015
3	Lasers (Laser) 01/2019 - 04/2006
2	Operative Surgical Procedures 05/2022 - 02/2017
2	Proctectomy 02/2017 - 12/2014
2	Microvascular Decompression Surgery 05/2015 - 02/2009
1	Craniotomy 11/2023
1	Proctoscopes (Proctoscope) 01/2023
1	Sclerotherapy 01/2023
1	Ileostomy 12/2021
1	Postoperative Care 09/2021
1	Minimally Invasive Surgical Procedures 09/2021
1	Radiotherapy 04/2021
1	Robotic Surgical Procedures 07/2015
1	Proton Therapy 12/2014